Nadroparin

Records for this ingredient, by country (identity only).

ATC B01AB · 6 markets · 77 records

Nadroparin 6 markets · 77 records Forms
Filters
MarketCN 49AU 9CA 8SG 8HK 2

CN 49 records · 6 shown of 6 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04 · some records have no stated strength

  • 0.6 mL per mL / per unit basis not statedinjection速碧林那屈肝素Manufacturer: 兆科药业(合肥)有限公司、Manufacturer: 天津红日药业股份有限公司、Manufacturer: 常州千红生化制药股份有限公司、Manufacturer: 河北常山生化药业股份有限公司、Manufacturer: 深圳赛保尔生物药业有限公司、Manufacturer: 烟台东诚北方制药有限公司
  • 0.4 mL per mL / per unit basis not statedinjection速碧林那屈肝素那赛畅、Manufacturer: 兆科药业(合肥)有限公司、Manufacturer: 天津红日药业股份有限公司、Manufacturer: 河北常山生化药业股份有限公司、Manufacturer: 深圳赛保尔生物药业有限公司、Manufacturer: 烟台东诚北方制药有限公司
  • 6,150 IU/0.6 mLinjectionManufacturer: 南京健友生化制药股份有限公司 ×4Manufacturer: 天津生物化学制药有限公司
  • 0.3 mL per mL / per unit basis not statedinjection速碧林那屈肝素Manufacturer: 常州千红生化制药股份有限公司
  • 4,100 IU/0.4 mLinjectionManufacturer: 天津生物化学制药有限公司 ×6
  • 3,075 IU/0.3 mLinjectionManufacturer: 南京健友生化制药股份有限公司 ×4
7 records · 1 manufacturers 7 registros · 1 fabricantes 7 个记录 · 1 个厂家 7 個記錄 · 1 個廠商
With a brand name Con nombre comercial 有商品名 有商品名立迈青 ×3

and 1 more (1 manufacturers) y 1 más (1 fabricantes) 还有 1 个（1 个厂家） 還有 1 個（1 個廠商）

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

AU 9 records · 9 shown of 9 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 9,500 anti per mL / per unit basis not statedinjectionFRAXIPARINE nadroparin calcium 1900IU anti-Xa/0.2mL unknown
  • 7,600 anti per mL / per unit basis not statedinjectionFRAXIPARINE nadroparin calcium 1900IU anti-Xa/0.2mL unknown
  • 5,700 anti per mL / per unit basis not statedinjectionFRAXIPARINE nadroparin calcium 1900IU anti-Xa/0.2mL unknown
  • 3,800 anti per mL / per unit basis not statedinjectionFRAXIPARINE nadroparin calcium 1900IU anti-Xa/0.2mL unknown
  • 2,850 anti per mL / per unit basis not statedinjectionFRAXIPARINE nadroparin calcium 1900IU anti-Xa/0.2mL unknown
  • 1,900 anti per mL / per unit basis not statedinjectionFRAXIPARINE nadroparin calcium 1900IU anti-Xa/0.2mL unknown
  • 19,000 anti per mL / per unit basis not statedinjectionFRAXIPARINE FORTE Nadroparin calcium 19,000 Anti- Xa IU/1.0mL injection syringe unknown
  • 15,200 anti per mL / per unit basis not statedinjectionFRAXIPARINE FORTE Nadroparin calcium 15,200 Anti- Xa IU/0.8mL injection syringe unknown
  • 11,400 anti per mL / per unit basis not statedinjectionFRAXIPARINE FORTE Nadroparin calcium 11,400 Anti- Xa IU/0.6mL injection syringe unknown

CA 8 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 8 records · 0 shown of 0 Source Health Sciences Authority (HSA) · Data as of 2026-08-07 · some records have no stated strength

8 records · 0 manufacturers 8 registros · 0 fabricantes 8 个记录 · 0 个厂家 8 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名FRAXIPARINE FORTE INJECTION 19,000 iu Axa/ml ×1FRAXIPARINE INJECTION 3800 IU AXA/0.4 mL ×36FRAXIPARINE MULTIDOSE INJECTION 9500 iu AXA/ml ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名FRAXIPARINE INJ 2850 IU AXA/0.3ML ×1FRAXIPARINE MULTIDOSE INJ 9500IU AXA/ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Also called: 那屈肝素钙 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.